Blood-Derivative Drugs. Blood-Derived Medicines . Drug Derivatives . Drugs Derived from Blood . Drugs Derived from Plasma . Hemoderived Products . Hemoderivative Drugs . Pharmaceuticals Derived from Blood . Plasma-Derived Medicines . Biological products derived from human plasma that undergo the processes of industrialization, standardization and quality control. . 1.00
Dextrans. Dextran . Dextran 40 . Dextran 40000 . Dextran 70 . Dextran 75 . Dextran 80 . Dextran B-1355 . Dextran B-1355-S . Dextran B1355 . Dextran B512 . Dextran Derivatives . Dextran M 70 . Dextran T 70 . Dextran T-40 . Dextran T-500 . Hemodex . Hyskon . Infukoll . Macrodex . Polyglucin . Promit . Rheodextran . Rheoisodex . Rheomacrodex . Rheopolyglucin . Rondex . Saviosol . Dextran B 1355 . Dextran B 1355 S . Dextran T 40 . Dextran T 500 . A group of glucose polymers made by certain bacteria. Dextrans are used therapeutically as plasma volume expanders and anticoagulants. They are also commonly used in biological experimentation and in industry for a wide variety of purposes. . 0.53
Hematoporphyrin Derivative. Hematoporphyrin YHPD . Photofrin I . WR-246310 . YHPD, Hematoporphyrin . Hematoporphyrin D . A complex mixture of monomeric and aggregated porphyrins used in the photodynamic therapy of tumors (HEMATOPORPHYRIN PHOTORADIATION). A purified component of this mixture is known as DIHEMATOPORPHYRIN ETHER. . 0.50
Activation, Metabolic. Drug Activation . Activation, Drug . Metabolic Activation . The conversion of an exogenous substance by a biological system resulting in the production on an active metabolite. . 0.49
Prodrugs. Pro-Drugs . Precursors, Drug . Pro Drugs . Drug Precursors . A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. . 0.46
